August 10, 2018

If the tables, charts, or other content in this email version of the newsletter do not display properly, please check it out at our at our blog HERE

To subscribe to our bulletins and receive content whenever it is published, subscribe at our blog HERE

EDITOR'S NOTE: We will be on a limited publication schedule later this month. Bulletins will be reduced the weeks of August 20-24 (we will publish M-W) and September 3-7 (we will publish W-F). There will be no bulletins the week of August 27-31. We will return to our normal publication schedule the week of September 10th.

This week, we provide top-five ranked VE data for our Medical Sector stocks. We take a look at our latest data on Snap Inc $SNAP and provide a free download link for our stock report on the company.

VALUATION WATCH: Overvalued stocks now make up 51.71% of our stocks assigned a valuation and 20.51% of those equities are calculated to be overvalued by 20% or more. Thirteen sectors are calculated to be overvalued.

ValuEngine Index Overview

Index	Week Open	Friday PM	Change	% Change	YTD
DJIA	25437.43	25342.53	-94.9	-0.37%	2.47%
NASDAQ	7809.54	7864.72	55.18	0.71%	13.90%
RUSSELL 2000	1673.25	1693.53	20.28	1.21%	10.34%
S&P 500	2840.29	2839.34	-0.95	-0.03%	6.15%

ValuEngine Market Overview

Summary of VE Stock Universe
Stocks Undervalued	48.29%
Stocks Overvalued	51.71%
Stocks Undervalued by 20%	19.12%
Stocks Overvalued by 20%	20.51%

ValuEngine Sector Overview

Sector	Change	MTD	YTD	Valuation	Last 12-MReturn	P/E Ratio
Computer and Technology	0.10%	2.73%	8.69%	16.07% overvalued	26.77%	31.97
Aerospace	-0.34%	-1.19%	7.33%	14.47% overvalued	18.45%	26.69
Retail-Wholesale	0.20%	1.04%	6.51%	10.24% overvalued	26.68%	24.28
Medical	0.03%	0.40%	14.71%	10.22% overvalued	42.88%	30.18
Multi-Sector Conglomerates	-0.26%	-0.31%	-1.52%	8.31% overvalued	7.47%	20.66
Business Services	0.05%	0.51%	10.53%	7.94% overvalued	22.91%	25.19
Consumer Discretionary	0.12%	0.96%	4.11%	5.99% overvalued	16.50%	26.58
Utilities	0.52%	1.20%	-3.43%	4.62% overvalued	-3.10%	20.01
Finance	0.02%	0.19%	2.53%	2.80% overvalued	8.01%	17.70
Consumer Staples	-0.07%	-0.78%	-1.42%	2.70% overvalued	10.62%	24.53
Auto-Tires-Trucks	0.29%	0.88%	-1.52%	1.29% overvalued	4.40%	12.76
Industrial Products	0.24%	0.57%	4.10%	1.07% overvalued	17.25%	25.35
Transportation	0.10%	0.16%	-0.14%	0.25% overvalued	15.67%	18.94
Construction	-0.05%	-1.24%	0.77%	4.25% undervalued	15.99%	21.17
Basic Materials	-0.36%	-1.27%	3.62%	8.19% undervalued	2.56%	20.98
Oils-Energy	0.42%	0.19%	8.95%	11.82% undervalued	17.98%	25.31

Want to learn more about ValuEngine? Our methods? Our history?
Check out our video presentation HERE

Sector Talk--Medical

Below, we present the latest data on Medical stocks from our Professional Stock Analysis Service. Top- five lists are provided for each category. We applied some basic liquidity criteria--share price greater than $3 and average daily volume in excess of 100k shares.

Top-Five Medical Stocks--Short-Term Forecast Returns

Ticker	Name	Mkt Price	Valuation (%)	Last 12-M Return (%)
IDRA	IDERA PHARMACT	7.31	230.40%	301.65%
ABUS	ARBUTUS BIOPH	9.8	128.85%	164.86%
FATE	FATE THERAPEUTC	11.42	159.65%	276.90%
XENE	XENON PHARMACT	12.1	117.54%	340.00%
ZGNX	ZOGENIX INC	50.1	173.29%	370.42%

Top-Five Medical Stocks--Momentum

Ticker	Name	Mkt Price	Valuation (%)	Last 12-M Return (%)
MDGL	MADRIGAL PHARMA	236.1	300.00%	1412.49%
MRTX	MIRATI THERAPTC	58.65	155.20%	1147.87%
ECYT	ENDOCYTE INC	16.29	124.20%	1106.67%
VKTX	VIKING THERAPTC	9.89	117.49%	957.87%
CDNA	CAREDX INC	14.97	77.24%	954.23%

Top-Five Medical Stocks--Composite Score

Ticker	Name	Mkt Price	Valuation (%)	Last 12-M Return (%)
NKTR	NEKTAR THERAP	59.37	-0.74%	217.83%
BHC	BAUSCH HEALTH	23.17	-19.76%	64.68%
THC	TENET HEALTH	32.48	-3.22%	140.06%
ESRX	EXPRESS SCRIPTS	81.82	0.39%	33.69%
ENDP	ENDO INTL PLC	15.83	17.36%	99.37%

Top-Five Medical Stocks--Most Overvalued

Ticker	Name	Mkt Price	Valuation (%)	Last 12-M Return (%)
MDGL	MADRIGAL PHARMA	236.1	300.00%	1412.49%
IMMU	IMMUNOMEDICS	23.29	300.00%	184.02%
EIGR	EIGER BIOPHARMA	9.85	300.00%	27.92%
LJPC	LA JOLLA PHARMA	24.465	286.56%	-23.09%
CASI	CASI PHARMACEUT	7.3	246.84%	637.37%

Free Download for Readers

As a bonus to our Free Weekly Newsletter subscribers,
we are offering a FREE DOWNLOAD of one of our Stock Reports

Snap Inc. (SNAP) provides technology and social media services. The Company's principal product Snapchat, is a camera application that helps people to communicate through short videos and images. Snap Inc. is headquartered in Venice, California.

VALUENGINE RECOMMENDATION: ValuEngine continues its HOLD recommendation on SNAP INC for 2018-08-09. Based on the information we have gathered and our resulting research, we feel that SNAP INC has the probability to ROUGHLY MATCH average market performance for the next year. The company exhibits ATTRACTIVE Company Size but UNATTRACTIVE Sharpe Ratio.

You can download a free copy of detailed report on Snap Inc. (SNAP) from the link below.

Read our Complete Rating and Forecast Report HERE.

ValuEngine Forecast
	Target Price*	Expected Return
1-Month	12.34	0.24%
3-Month	12.67	2.94%
6-Month	12.84	4.34%
1-Year	12.66	2.84%
2-Year	13.37	8.65%
3-Year	13.12	6.60%

Valuation & Rankings
Valuation	n/a	Valuation Rank(?)	n/a
1-M Forecast Return	0.24%	1-M Forecast Return Rank	68
12-M Return	-9.22%	Momentum Rank(?)	21
Sharpe Ratio	-0.96	Sharpe Ratio Rank(?)	6
5-Y Avg Annual Return	-44.18%	5-Y Avg Annual Rtn Rank	11
Volatility	45.88%	Volatility Rank(?)	35
Expected EPS Growth	2.98%	EPS Growth Rank(?)	23
Market Cap (billions)	8.15	Size Rank	86
Trailing P/E Ratio	n/a	Trailing P/E Rank(?)	17
Forward P/E Ratio	n/a	Forward P/E Ratio Rank	n/a
PEG Ratio	3.69	PEG Ratio Rank	9
Price/Sales	8.99	Price/Sales Rank(?)	13
Market/Book	4.09	Market/Book Rank(?)	33
Beta	-2.57	Beta Rank	98
Alpha	0.25	Alpha Rank	87

ValuEngine.com is an Independent Research Provider (IRP), producing buy/hold/sell recommendations, target price, and valuations on over 5,000 US and Canadian equities every trading day.
Contact ValuEngine at (321) 325-0519 or support@valuengine.com
Visit www.ValuEngine.com for more information

ValuEngine Capital Management LLC is a Registered Investment Advisory (RIA) firm that trades client accounts using ValuEngine's award-winning stock research.
Contact ValuEngine Capital at info@valuenginecapital.com
Visit www.ValuEngineCapital.com for more information

Steve Hach
Senior Editor
ValuEngine.com